Expression of cyclins A and D and p21((waf1/cip1)) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival

British Journal of Cancer

Volumn 80, Issue 12, 1999, Pages 2001-2007

  Aaltomaa, S ^a   Lipponen, P ^a   Ala Opas, M ^a   Eskelinen, M ^a   Syrjanen K ^a,b   Kosma, V M ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cell proliferation; Cyclin A; Cyclin D1; p21((waf1 cip1)); Renal cell carcinoma

Indexed keywords

ANTIBODY; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; KI 67 ANTIGEN; PROTEIN P21;

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; MITOSIS RATE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, RENAL CELL; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; KIDNEY NEOPLASMS; MIDDLE AGED; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032814293     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690634     Document Type: Article

References (40)

1. Aaltomaa S, Lipponen P, Vesalainen S, Eskelinen M and Syrjänen K (1997) Value of Ki-67 expression in renal cell carcinomas. Eur Urol 32: 350-355
2. Aaltomaa S, Eskelinen M and Lipponen P (1999a) Expression of cyclin A and D proteins in prostate cancer and their relation to clinicopathological variables and patient survival. Prostate 30: 175-182
3. (waf1/cip1) protein in prostate cancer. Prostate 39: 8-15
4. Backe J, Gassel AM, Hauber K, Krebs S, Bartek J, Caffier H, Kreibe HH, Muller-Hermelink HK and Dietl J (1997) p53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein. Int J Gynecol Pathol 16: 361-368
5. Barbareschi M, Pelosio P, Caffo O, Buttilla F, Pellegrini S, Barbazza R, Dalla Parma P, Bevilacqua G and Marchetti A (1997) Cyclin D1 gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21/wafl immunohistochemical expression. Int J Cancer 74: 171-174
6. Barbieri F, Cagnoli M, Ragni N, Pedulla F, Foglia G and Alama A (1997) Expression of cyclin D1 correlates with malignancy in human ovarian tumors. Br J Cancer 75: 1263-1268
7. Byrne RL, Horne CH, Robinson MC, Autzen P, Apakama I, Bishop RI, Neal DE and Hamdy FC (1997) The expression of waf-1. p53 and bcl-2 in prostatic adenocarcinoma. Br J Urol 79: 190-195
8. Donnellan R and Chetty R (1998) Cyclin D1 and human neoplasia. J Clin Pathol Mol Pathol 51: 1-7
9. (waf1/cip1) expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919
10. Giberti C, Oneto F, Martorana G, Rovida S and Carmignani G (1997) Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol 31: 40-48
11. Gillet CE, Smith P, Gregory WM, Richards MA, Mills RR, Peters G and Barnes DM (1996) Cyclin D1 and prognosis in breast cancer. Int J Cancer 69: 92-99
12. Haapasalo H, Pesonen E and Collan Y (1989) Volume corrected mitotic index (M/V-INDEX): the standard of mitotic activity in neoplasms. Path Res Prac 185: 551-554
13. Hofmockel G, Bassukas ID, Wittmann A and Dämmrich J (1997) Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cell cancer? Br J Urol 80: 11-17
14. Ishikawa T, Furihata M, Ohtsuki Y, Murakami M, Inoue A and Ogoshi S (1998) Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 77: 92-97
15. Kato JY (1997) Control of G1 progression by D-types cyclins: key event for cell proliferation. Leukemia 3: 347-351
16. Kawasaki T, Tomita Y, Bilim V, Takeda M, Takahashi K and Kumanishi T (1998) Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/waf1/cip1 and/or p53 gene alterations. Int J Cancer 68: 501-505
17. Koga H, Naito S, Hasegawa S, Watanabe T and Kumazawa J (1997) A flow cytometric analysis of the expression of adhesion molecules on human renal cell carcinoma cells with different metastatic potentials. Eur Urol 31: 86-91
18. Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, Nakatani T, Wada S, Kishimoto T and Fukushima S (1997) Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 15: 780-789
19. (waf1/cip1) protein in transitional cell bladder tumours and its prognostic value. Eur Urol 34: 237-243
20. Lipponen P, Eskelinen M, Hietala K and Syrjänen K (1994) Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma. Int J Cancer 57: 275-280
21. Maeda K, Chung Y, Kang S, Ogawa M, Nishiguchi Y, Ikehara T, Nakata B, Okuno M and Sowa M (1998) Cyclin D1 overexpression and prognosis in colorectal adenocarcinoma. Oncology 55: 145-151
22. Marshall RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ and Dutta A (1996) Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 56: 4159-4163
23. Michalides RJ, van Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ and Balm JA (1997) Over-expression of cyclin D1 indicates poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123: 497-502
24. Naitoh H, Shibata J, Kawaguchi A, Kodama M and Hattori T (1995) Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146: 1161-1169
25. Naka T, Toyota N, Kaneko T and Kaibara N (1998) Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res 18: 555-564
26. Nakamura M, Katano M, Fujimoto K and Morisaki T (1997) A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens. Ann Surg 226: 35-42
27. Papandopoulos I, Rudolph P and Weichert-Jacobsen K (1997) Value of p53 expression, cellular proliferation and DNA content as prognostic indicators in renal cell carcinoma. Eur Urol 32: 110-117
28. (waf1/cip1) gene in renal cancers. Urology 49: 481-486
29. Paul R, Ewing CM, Robinson JC, Marshall FF, Johnson KR, Wheelock MJ and Isaacs WB (1998) Catherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma. Cancer Res 57: 2741-2748
30. Pignataro L, Pruneri G, Carboni N, Capaccio P, Cesana BM, Neri A and Butler MR (1998) Clinical relevance of cyclin D1 protein expression in laryngeal squamous cell carcinomas. J Clin Oncol 16: 3069-3077
31. Shiina H, Igawa M, Urakami S, Ishibe T and Kawanishi M (1997) Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma. Eur Urol 31: 73-80
32. Shin KY, Kong G, Kim WS, Lee TY, Woo YN and Lee JD (1997) Over-expression of cyclin D1 correlates with early recurrence in superficial bladder cancer. Br J Cancer 75: 1788-1792
33. Strauss M, Lukas J and Bartek J (1995) Unrestricted cell cycling and cancer. Recent data suggest that de-regulation of the restriction point in the cell cycle G1 phase appears to be required for the development of neoplasia. Nat Med 1: 1245-1246
34. Sweeney JP, Thomhill JA, Grainger R, Medermott TED and Butler MR (1996) Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment. Br J Urol 78: 351-353
35. Syrjänen K and Hjelt L (1978) Grading of human renal adenocarcinoma. Scand J Urol Nephrol 12: 49-52
36. Volm M, Koomagi R and Rittgen W (1998) Clinical implication of cyclins, cyclin dependent kinases, RB and E2F1 in squamous-cell lung carcinoma. Int J Cancer 79: 294-299
37. Waga S, Hannon GJ, Beach D and Stillman B (1994) The p21 inhibitor of cyclin dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578
38. Yasui W, Akama Y, Yokozaki H, Semba S, Kudo Y, Shimamoto F and Tahara E (1997) Expression of p21 wafl/cipl in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression stage, Pathol Int 47: 470-477
39. Zhang H, Hannon GJ and Beach D (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750-1758
40. (waf1/cip1) expression by p53-independent pathways. Oncogene 12: 1557-1564